30 Recruiting Studies Using Panitumumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Panitumumab
CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab
📍 The University of Kansas Cancer Center (KUCC) — Fairway, Kansas
Colon Cancer
View Study & Checklist ➔Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Breast Carcinoma
View Study & Checklist ➔Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer
📍 M D Anderson Cancer Center — Houston, Texas
EGFR NP_005219.2:p.S492R
View Study & Checklist ➔Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer
📍 Emory University Hospital Midtown — Atlanta, Georgia
Advanced Microsatellite Stable Colorectal Carcinoma
View Study & Checklist ➔Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
📍 Arizona Oncology Associates Professional Corporation — Tucson, Arizona
Advanced Solid Tumors
View Study & Checklist ➔Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
Metastatic Colorectal Cancer
View Study & Checklist ➔Botensilimab and Balstilimab Optimization in Colorectal Cancer
📍 Duke University — Durham, North Carolina
Colorectal Cancer
View Study & Checklist ➔Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
BRAF V600E Negative
View Study & Checklist ➔ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
📍 MD Anderson Cancer Center — Houston, Texas
Dynamic Tumor Resistance
View Study & Checklist ➔AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
📍 City of Hope National Medical Center — Duarte, California
KRAS Altered Advanced or Metastatic Solid Tumors
View Study & Checklist ➔Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Metastatic Colorectal Carcinoma
View Study & Checklist ➔Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
📍 Ironwood Cancer and Research Centers Scottsdale — Chandler, Arizona
Metastatic Colorectal Cancer
View Study & Checklist ➔Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer
📍 Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee
Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
📍 Stanford University, School of Medicine — Palo Alto, California
Pancreatic Adenocarcinoma
View Study & Checklist ➔A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
📍 City of Hope National Medical Center /ID# 270255 — Duarte, California
Metastatic Colorectal Cancer
View Study & Checklist ➔(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma
📍 Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee
Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
📍 UCLA Santa Monica Hematology Oncology — Santa Monica, California
Solid Tumor
View Study & Checklist ➔Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
📍 Vanderbilt University Medical Center — Nashville, Tennessee
Meningioma
View Study & Checklist ➔Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
📍 Stanford University School of Medicine — Palo Alto, California
Malignant Brain Neoplasm
View Study & Checklist ➔Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer
📍 Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee
Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
📍 Florida Cancer Specialists - Fort Myers — Fort Myers, Florida
Advanced Solid Tumors
View Study & Checklist ➔Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Locally Advanced Pancreatic Adenocarcinoma
View Study & Checklist ➔Phase II Panitumumab-IRDye800 in Head & Neck Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
Head and Neck Cancer
View Study & Checklist ➔Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
📍 Stanford University, School of Medicine — Palo Alto, California
Lung Carcinoma
View Study & Checklist ➔Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
📍 Stanford Cancer Center — Stanford, California
Brain Tumor
View Study & Checklist ➔A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
📍 START Los Angeles — Los Angeles, California
Colorectal Cancer
View Study & Checklist ➔Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
📍 Banner Health- MD Anderson Cancer Center — Gilbert, Arizona
Non-small Cell Lung Cancer
View Study & Checklist ➔Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
📍 Vanderbilt University Medical Center — Nashville, Tennessee
HNSCC
View Study & Checklist ➔